Heinz Christoph Maeusli's Net Worth
$3.41 Million
Who is Heinz Christoph Maeusli?
Heinz Christoph Maeusli has an estimated net worth of $3.41 Million. This is based on reported shares across multiple companies, which include Lantheus Holdings, Inc., and PROGENICS PHARMACEUTICALS INC.
SEC CIK
Heinz Christoph Maeusli's CIK is 0001788919
Past Insider Trading and Trends
2021 was Heinz Christoph Maeusli's most active year for acquiring shares with 9 total transactions. Heinz Christoph Maeusli's most active month to acquire stocks was the month of April. 2024 was Heinz Christoph Maeusli's most active year for disposing of shares, totalling 5 transactions. Heinz Christoph Maeusli's most active month to dispose stocks was the month of April. 2024 saw Heinz Christoph Maeusli paying a total of $282,667.77 for 24,969 shares, this is the most they've acquired in one year. In 2024 Heinz Christoph Maeusli cashed out on 35,854.326 shares for a total of $1,454,989.48, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Lantheus Holdings, Inc. (LNTH) Snapshot price: $101.98
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.22% | -892.33 |
$47.68 | -$1,172,321.71 | 72.37K |
May 28
| |||
Form 4
| +9.11% | 2.63K |
—
|
—
| 31.55K |
May 9
| |||
Form 4
| +7.48% | 2.01K |
—
|
—
| 28.92K |
May 11
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
| +8.82% | 2.18K |
—
|
—
| 26.9K |
May 6
| |||
Form 4
| +52.51% | 8.51K |
—
|
—
| 24.72K |
May 10
| |||
Form 4
| +6.57% | 1K |
$18.60 | $18,600.00 | 16.21K |
Scheduled
|
Mar 5
| ||
Form 4
| +7.04% | 1K |
$18.02 | $18,020.00 | 15.21K |
Scheduled
|
Feb 26
| ||
Form 4
| +7.57% | 1K |
$19.39 | $19,390.00 | 14.21K |
Scheduled
|
Feb 19
| ||
Form 4
| +8.19% | 1K |
$20.03 | $20,030.00 | 13.21K |
Scheduled
|
Feb 12
| ||
Form 4
| +8.92% | 1K |
$17.94 | $17,940.00 | 12.21K |
Scheduled
|
Feb 5
| ||
Form 4
| +9.79% | 1K |
$16.13 | $16,130.00 | 11.21K |
Scheduled
|
Jan 29
| ||
Form 4
| +10.86% | 1K |
$15.29 | $15,290.00 | 10.21K |
Scheduled
|
Jan 22
| ||
Form 4
| +12.18% | 1K |
$15.80 | $15,800.00 | 9.21K |
Scheduled
|
Jan 15
| ||
Form 4
| +18.95% | 1.31K |
—
|
—
| 8.21K |
Oct 1
| |||
Form 4
| +15.42% | 922 |
—
|
—
| 6.9K |
Aug 10
| |||
Form 4
|
∞
| 5.98K |
—
|
—
| 5.98K |
Jun 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PROGENICS PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||